Jefferson Regional Hospital’s Urology Associates will be participating in what’s being called a “March Madness Wellness Event ...

SESAUA annual meeting featured a kidney cancer session and a presentation by Dr. Robert Smith discussing how age and tumor ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

The management and treatment of prostate cancer is evolving to address unmet patient needs, with advancements spanning from diagnosis ...

Christ must pay a $7,500 fine and $6,384 in Florida Department of Health investigation reimbursement; complete two five-hour ...

A team from the Universitat Politècnica de València (UPV) and the Spanish National Research Council (CSIC), belonging to the Research Institute for Molecular Imaging Technologies (I3M), has developed, ...

Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several ...

The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...